COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
Matucci A, Caminati M, Vivarelli E, Vianello A, Micheletto C, Menzella F, Crisafulli E, Passalacqua G, Bagnasco D, Lombardi C, Parronchi P, Crivellaro MA, Chieco-Bianchi F, Rita Marchi M, Guarnieri G, Cosmi L, Rossi O, Almerigogna F, Senna G, Vultaggio A.
Matucci A, et al. Among authors: guarnieri g.
Allergy. 2021 Mar;76(3):871-874. doi: 10.1111/all.14516. Epub 2020 Aug 11.
Allergy. 2021.
PMID: 32716580
No abstract available.